根据INTETREST试验结果分析预测吉非替尼和多烯紫杉醇对非小细胞肺癌患者疗效的生物学标志物
评价者:杨衿记, 文献合成者:张一方

Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer:Data from the Randomized Phase Ⅲ INTEREST Trial
Reviewer:YANG Jin-ji, Literature Co-worker: ZHANG Yi-fang
图1 INTEREST试验设计流程图